BackG Medical Innovations Holdings Overview

G Medical Innovations Holdings Profit Margin

Latest profit margin for G Medical Innovations Holdings: -116.04% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-585.48%

As of Jun 2022

Annual Profit Margin (TTM)

-116.04%
↑ 79.07% YoY

Trailing 12 months ending Jun 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

G Medical Innovations Holdings (GMVDF) FAQ

The latest profit margin for GMVDF is -116.04% as of June 2022. That compares with -554.41% in the prior-year period — up 79.1% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside G Medical Innovations Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, GMVDF's profit margin moved from -554.41% to -116.04% — a 79.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in G Medical Innovations Holdings's valuation or profitability profile.

Against Healthcare companies, GMVDF currently prints -116.04% for profit margin, while the sector average sits near 17.63%. That is roughly 758.2% below the sector mean. Large gaps often invite a closer look at G Medical Innovations Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively G Medical Innovations Holdings converts resources into returns. At -116.04%, GMVDF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -554.41% in the prior-year period — up 79.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GMVDF's profit margin (-116.04%), review year-over-year change from -554.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.